We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sponsors planning clinical trials in foreign countries must learn about and follow local laws and regulations, said experts speaking at Public Responsibility in Medicine and Research’s Annual Human Research Protection Programs Conference last month.